SG11202108881WA - Treatment of herpes simplex with a combination of valacyclovir and famciclovir - Google Patents

Treatment of herpes simplex with a combination of valacyclovir and famciclovir

Info

Publication number
SG11202108881WA
SG11202108881WA SG11202108881WA SG11202108881WA SG11202108881WA SG 11202108881W A SG11202108881W A SG 11202108881WA SG 11202108881W A SG11202108881W A SG 11202108881WA SG 11202108881W A SG11202108881W A SG 11202108881WA SG 11202108881W A SG11202108881W A SG 11202108881WA
Authority
SG
Singapore
Prior art keywords
valacyclovir
famciclovir
treatment
combination
herpes simplex
Prior art date
Application number
SG11202108881WA
Inventor
Emidio Checcone
Christina Ramirez
Original Assignee
Elian Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elian Llc filed Critical Elian Llc
Publication of SG11202108881WA publication Critical patent/SG11202108881WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202108881WA 2019-02-25 2020-02-25 Treatment of herpes simplex with a combination of valacyclovir and famciclovir SG11202108881WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962810074P 2019-02-25 2019-02-25
PCT/US2020/019700 WO2020176506A1 (en) 2019-02-25 2020-02-25 Treatment of herpes simplex with a combination of valacyclovir and famciclovir

Publications (1)

Publication Number Publication Date
SG11202108881WA true SG11202108881WA (en) 2021-09-29

Family

ID=70228783

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202108881WA SG11202108881WA (en) 2019-02-25 2020-02-25 Treatment of herpes simplex with a combination of valacyclovir and famciclovir

Country Status (12)

Country Link
US (2) US11696918B2 (en)
EP (1) EP3930721A1 (en)
JP (1) JP2022521651A (en)
KR (1) KR20210131394A (en)
CN (1) CN113727715A (en)
AU (1) AU2020228361A1 (en)
BR (1) BR112021016669A2 (en)
CA (1) CA3131159A1 (en)
IL (1) IL285742A (en)
MX (1) MX2021010063A (en)
SG (1) SG11202108881WA (en)
WO (1) WO2020176506A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071745B2 (en) * 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
WO2022197625A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2022197626A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2022197627A1 (en) * 2021-03-15 2022-09-22 Drugarray, Inc. Combination therapy for treating covid-19
WO2024097158A1 (en) * 2022-11-01 2024-05-10 Ramirez Christina M Viral prophylaxis treatment methods and pre-exposure prophylaxis kits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107303A (en) 1999-03-15 2000-08-22 Demarco; Charlene C. Treatment of Epstein Barr infection
US7253175B2 (en) 2003-11-13 2007-08-07 Barnet Liberman Method for treating athlete's foot
SG11201700061PA (en) * 2014-07-07 2017-02-27 Prophylaxis LLC Viral prophylaxis treatment methods and pre-exposure prophylaxis kits

Also Published As

Publication number Publication date
US20200397791A1 (en) 2020-12-24
MX2021010063A (en) 2021-11-12
US11696918B2 (en) 2023-07-11
EP3930721A1 (en) 2022-01-05
KR20210131394A (en) 2021-11-02
BR112021016669A2 (en) 2021-11-09
JP2022521651A (en) 2022-04-11
AU2020228361A1 (en) 2021-10-07
WO2020176506A1 (en) 2020-09-03
US20230310439A1 (en) 2023-10-05
CN113727715A (en) 2021-11-30
CA3131159A1 (en) 2020-09-03
IL285742A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
IL285742A (en) Treatment of herpes simplex with a combination of valacyclovir and famciclovir
HK1254293A1 (en) Recombinant herpes simplex virus and use thereof
ZA201704840B (en) Rna guided eradication of herpes simplex type i and other related herpesviruses
AU201714948S (en) Kettle
EP4034094A4 (en) Phosphodiesterase inhibitors and use
AU201715447S (en) Carafe
IL278892A (en) Antigen variant of varicella zoster virus and use thereof
EP3757663A4 (en) Functional multilayer body and functional lens using functional multilayer body
SG11201913845YA (en) Reflective photomask blank and reflective photomask
EP3829608A4 (en) Compositions comprising herpes simplex virus-1 for use in methods of treating and preventing cancer
IL288944A (en) Deuterated caffeine and uses thereof
EP3847137A4 (en) Hollow glass body and use of a hollow glass body
IL292155A (en) Stimulation of neuronal plasticity
EP4112724A4 (en) Herpes simplex virus and use thereof
IL280773B1 (en) Faceted gemstone with enhanced color dispersion and diminished haze
ZA202202617B (en) Treatment of cancer using a combination comprising multi-tyrosine kinase inhibitor and immune checkpoint inhibitor
EP3583939C0 (en) Autoassociative acrylic functional copolymers and terpolymers and their use as vehicles of bioactive compounds
GB202204953D0 (en) Scope and monocular
EP3722929A4 (en) Electronic pen and electronic pen main body part
ZA202103997B (en) Treadmill with lighting and safety features
EP3594328A4 (en) Recombinant herpes simplex virus and use thereof
PL3867282T3 (en) Conjugates of hyaluronic acid and aminobisphosphonates and the therapeutic use thereof
EP3752517A4 (en) Cyclin-dependent kinase degraders and methods of use
GB202011148D0 (en) Use of cannabidiol in the treatment of seizures associated with herpes simplex virus
GB201807428D0 (en) Light up face and body gems